Immediate impact of healthcare-facility-onset Clostridium difficile laboratory-identified events reporting methodology change on standardized infection ratios

Carlos E. Figueroa Castro; Louis Palen; Carrie Johnson; Mary Beth Graham; David Letzer; Nathan Ledeboer; Blake Buchan; Timothy Block; Heather Seliger; Siddhartha Singh; Elizabeth Behrens; Susan Huerta; Luisa Munoz-Price

doi:10.1017/ice.2018.241

Immediate impact of healthcare-facility-onset Clostridium difficile laboratory-identified events reporting methodology change on standardized infection ratios

Carlos E. Figueroa Castro, Louis Palen, Carrie Johnson, Mary Beth Graham, David Letzer, Nathan Ledeboer, Blake Buchan, Timothy Block, Heather Seliger, Siddhartha Singh, Elizabeth Behrens, Susan Huerta, Luisa Munoz-Price

Medicine

Research output: Contribution to journal › Article

Abstract

In 2018, the Clostridium difficile LabID event methodology changed so that hospitals doing 2-step tests, nucleic acid amplification test (NAAT) plus enzyme immunofluorescence assay (EIA), had their adjustment modified to EIA-based tests, and only positive final tests (eg, EIA) were counted in the numerator. We report the immediate impact of this methodological change at 3 Milwaukee hospitals.

Original language	English (US)
Journal	Infection Control and Hospital Epidemiology
DOIs	https://doi.org/10.1017/ice.2018.241
State	Accepted/In press - Jan 1 2018

Fingerprint

ASJC Scopus subject areas

Epidemiology
Microbiology (medical)
Infectious Diseases

Cite this

Figueroa Castro, C. E., Palen, L., Johnson, C., Graham, M. B., Letzer, D., Ledeboer, N., Buchan, B., Block, T., Seliger, H., Singh, S., Behrens, E., Huerta, S., & Munoz-Price, L. (Accepted/In press). Immediate impact of healthcare-facility-onset Clostridium difficile laboratory-identified events reporting methodology change on standardized infection ratios. Infection Control and Hospital Epidemiology. https://doi.org/10.1017/ice.2018.241

Immediate impact of healthcare-facility-onset Clostridium difficile laboratory-identified events reporting methodology change on standardized infection ratios. / Figueroa Castro, Carlos E.; Palen, Louis; Johnson, Carrie; Graham, Mary Beth; Letzer, David; Ledeboer, Nathan; Buchan, Blake; Block, Timothy; Seliger, Heather; Singh, Siddhartha; Behrens, Elizabeth; Huerta, Susan; Munoz-Price, Luisa.

In: Infection Control and Hospital Epidemiology, 01.01.2018.

Research output: Contribution to journal › Article

Figueroa Castro, CE, Palen, L, Johnson, C, Graham, MB, Letzer, D, Ledeboer, N, Buchan, B, Block, T, Seliger, H, Singh, S, Behrens, E, Huerta, S & Munoz-Price, L 2018, 'Immediate impact of healthcare-facility-onset Clostridium difficile laboratory-identified events reporting methodology change on standardized infection ratios', Infection Control and Hospital Epidemiology. https://doi.org/10.1017/ice.2018.241

Figueroa Castro, Carlos E. ; Palen, Louis ; Johnson, Carrie ; Graham, Mary Beth ; Letzer, David ; Ledeboer, Nathan ; Buchan, Blake ; Block, Timothy ; Seliger, Heather ; Singh, Siddhartha ; Behrens, Elizabeth ; Huerta, Susan ; Munoz-Price, Luisa. / Immediate impact of healthcare-facility-onset Clostridium difficile laboratory-identified events reporting methodology change on standardized infection ratios. In: Infection Control and Hospital Epidemiology. 2018.

@article{9f6082c2a40240cbaf331094ceb11d39,

title = "Immediate impact of healthcare-facility-onset Clostridium difficile laboratory-identified events reporting methodology change on standardized infection ratios",

abstract = "In 2018, the Clostridium difficile LabID event methodology changed so that hospitals doing 2-step tests, nucleic acid amplification test (NAAT) plus enzyme immunofluorescence assay (EIA), had their adjustment modified to EIA-based tests, and only positive final tests (eg, EIA) were counted in the numerator. We report the immediate impact of this methodological change at 3 Milwaukee hospitals.",

author = "{Figueroa Castro}, {Carlos E.} and Louis Palen and Carrie Johnson and Graham, {Mary Beth} and David Letzer and Nathan Ledeboer and Blake Buchan and Timothy Block and Heather Seliger and Siddhartha Singh and Elizabeth Behrens and Susan Huerta and Luisa Munoz-Price",

year = "2018",

month = jan

day = "1",

doi = "10.1017/ice.2018.241",

language = "English (US)",

journal = "Infection Control and Hospital Epidemiology",

issn = "0899-823X",

publisher = "University of Chicago Press",

}

TY - JOUR

T1 - Immediate impact of healthcare-facility-onset Clostridium difficile laboratory-identified events reporting methodology change on standardized infection ratios

AU - Figueroa Castro, Carlos E.

AU - Palen, Louis

AU - Johnson, Carrie

AU - Graham, Mary Beth

AU - Letzer, David

AU - Ledeboer, Nathan

AU - Buchan, Blake

AU - Block, Timothy

AU - Seliger, Heather

AU - Singh, Siddhartha

AU - Behrens, Elizabeth

AU - Huerta, Susan

AU - Munoz-Price, Luisa

PY - 2018/1/1

Y1 - 2018/1/1

N2 - In 2018, the Clostridium difficile LabID event methodology changed so that hospitals doing 2-step tests, nucleic acid amplification test (NAAT) plus enzyme immunofluorescence assay (EIA), had their adjustment modified to EIA-based tests, and only positive final tests (eg, EIA) were counted in the numerator. We report the immediate impact of this methodological change at 3 Milwaukee hospitals.

AB - In 2018, the Clostridium difficile LabID event methodology changed so that hospitals doing 2-step tests, nucleic acid amplification test (NAAT) plus enzyme immunofluorescence assay (EIA), had their adjustment modified to EIA-based tests, and only positive final tests (eg, EIA) were counted in the numerator. We report the immediate impact of this methodological change at 3 Milwaukee hospitals.

UR - http://www.scopus.com/inward/record.url?scp=85055537816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055537816&partnerID=8YFLogxK

U2 - 10.1017/ice.2018.241

DO - 10.1017/ice.2018.241

M3 - Article

AN - SCOPUS:85055537816

JO - Infection Control and Hospital Epidemiology

JF - Infection Control and Hospital Epidemiology

SN - 0899-823X

ER -

Access to Document

10.1017/ice.2018.241